Tissue Hypoxia

Tissue hypoxia is a medical condition in which the body's tissues do not receive adequate oxygen supply. This can occur due to various reasons, including respiratory diseases, heart diseases, and anemia. Hypoxia can also be a symptom of several medical conditions, such as pneumonia, chronic obstructive pulmonary disease (COPD), lung cancer, or COVID-19. Coronaviruses, a large family of viruses that also cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), can lead to tissue hypoxia in severe cases. COVID-19, caused by SARS-CoV-2, is currently a global pandemic, and it can cause severe respiratory symptoms, including hypoxia. In severe cases, COVID-19 can cause a cytokine storm, triggering inflammation in the body and respiratory distress syndrome, leading to severe hypoxia. Inadequate oxygen supply can lead to tissue damage or even failure, highlighting the importance of prompt diagnosis and treatment of hypoxia. Treatment options may include oxygen therapy, breathing assistance devices, and medications aimed at improving oxygen delivery to the tissues. The International Journal of Coronaviruses is committed to contributing to the advancement of research on coronaviruses, including their pathogenesis, diagnosis, and treatment, particularly in the context of COVID-19. This journal provides a platform for researchers and healthcare professionals to share their knowledge and findings that can help improve the understanding and management of tissue hypoxia in patients with COVID-19 and other coronaviruses.